(Q377270)

DIHYDROCODEINE (English)

18 November 2016

1 reference

C₁₈H₂₃NO₃

1 reference

DIHYDROCODEINE (English)

18 November 2016

canonical SMILES

CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(CC4)O

1 reference

DIHYDROCODEINE (English)

18 November 2016

isomeric SMILES

CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O

1 reference

DIHYDROCODEINE (English)

https://www.whocc.no/atc_ddd_index/?code=N02AA08

18 November 2016

defined daily dose

0.15 gram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

Dihydrocodeine (English)

1 reference

Chemiluminescence detection of opium poppy (Papaver somniferum) alkaloids

Dihydrocodeine (English)

19 January 2016

1 reference

medical condition treated

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

remifentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

remifentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimeprazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimeprazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

0 references

opioid receptor agonist

1 reference

5 March 2018

1 reference

Medical Subject Headings

15 March 2018

Dihydrcodeine Tablets Package Almus 30 mg 2017.jpg
3,857 × 1,518; 737 KB

0 references

Dihydrocodéine.jpg
4,161 × 2,822; 2.46 MB

0 references

0 references

0 references

0 references

0 references

Dihydrocodeine

0 references

Identifiers

InChI

InChI=1S/C18H23NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1

1 reference

DIHYDROCODEINE (English)

RBOXVHNMENFORY-DNJOTXNNSA-N

18 November 2016

InChIKey

2 references

DIHYDROCODEINE (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

125-28-0

2 references

dihydrocodeine (English)

RBOXVHNMENFORY-DNJOTXNNSA-N

18 November 2016

InChIKey

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=125-28-0

1 reference

Dihydrocodeine (English)

18 November 2016

1 reference

DIHYDROCODEINE (English)

18 November 2016

ChEBI ID

135276

mapping relation type

exact match

1 reference

ChEBI release 2019-10-02

1 reference

MSBNK-Athens_Univ-AU217801

DIHYDROCODEINE (English)

18 November 2016

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU217802

0 references

MSBNK-Athens_Univ-AU217803

0 references

MSBNK-Athens_Univ-AU217804

0 references

MSBNK-Athens_Univ-AU217805

0 references

MSBNK-Athens_Univ-AU217807

0 references

MSBNK-Athens_Univ-AU217808

0 references

MSBNK-Athens_Univ-AU217809

0 references

MSBNK-Athens_Univ-AU217810

0 references

MSBNK-Athens_Univ-AU217811

0 references

MSBNK-Athens_Univ-AU217830

0 references

MSBNK-Athens_Univ-AU217831

0 references

MSBNK-Athens_Univ-AU217832

0 references

0 references

0 references

0 references

0 references

0 references

0 references

splash10-0udi-0009000000-215351ab6e3d6923cb7a

0 references

splash10-0udi-0239000000-d9a28afb4f2a26a792fb

0 references

splash10-0f6t-0931000000-8f6a91fec0761febddae

0 references

splash10-006t-0910000000-b17807fd1304c69ce71d

0 references

splash10-0udi-0009000000-422aaa0732f083783954

0 references

splash10-0udi-0009000000-6826eb02e5bf4f87fde7

0 references

splash10-0udi-0359000000-b1a87ac83b5ead5b10ba

0 references

splash10-0f6t-0941000000-85f127ae74a67d7544d7

0 references

splash10-006t-0910000000-fc3b87d3fb93d21f90f4

0 references

splash10-062d-0900000000-c8e88928923875169e0b

0 references

DSSTox substance ID

DTXSID5022936

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

204-732-3

1 reference

dihydrocodeine (English)

ECHA Substance Infocard ID

18 November 2016

100.004.303

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.004.303

27 December 2018

Dihydrocodeine (English)

quotation

CAS no.: 125-28-0 (English)

1 reference

Guide to Pharmacology Ligand ID

Dihydrocodeine (English)

publication date

17 November 2015

7594

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7594

dihydrocodeine (English)

18 November 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

dihydrocodeine (English)

18 November 2016

1 reference

Dihydrocodeine (English)

18 November 2016

1 reference

dihydrocodeine (English)

18 November 2016

1 reference

dihydrocodeine (English)

18 November 2016

0 references

1 reference

1 reference

imported from Wikimedia project

Dihydrocodeine (English)

19 January 2016

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

1 reference

1 reference

dihydrocodeine (English)